Tirzepatide and the Dual Incretin Mechanism
Tirzepatide is an approved molecule that carries both incretin hormones in a single peptide, and the trial record that followed […]
GLP-1 & Metabolic
Semaglutide: How the First Oral GLP-1 Changed Metabolic Medicine
The story of semaglutide is the story of a peptide that crossed the last barrier in drug delivery, and the
What the Evidence Says About Peptide Stacks for Weight Loss
The marketed peptide stacks for weight loss all run ahead of the evidence, so this article maps each compound to
What Happens When You Stop GLP-1 Therapy
The withdrawal trials and real-world cohorts now quantify what comes back when GLP-1 therapy stops, and the honest answer mixes
GLP-1 peptides and the muscle loss problem
The rapid weight loss produced by semaglutide, tirzepatide, and the emerging triple-agonist retatrutide has generated a familiar cycle of concern
How GLP-1 peptides are reshaping metabolic medicine
The GLP-1 receptor agonist class has moved from a niche diabetes therapy to the center of metabolic medicine in less